ロード中...
A new Tie1 targeted antibody blocks tumor cell extravasation and metastasis
Targeting the metastatic process is a critical pursuit in the treatment of malignant disease. There are currently no specific anti‐metastatic drugs approved for clinical use, despite metastasis being the leading cause of death for cancer patients. Targeting the Tie1 receptor was shown as a possible...
保存先:
| 出版年: | EMBO Mol Med |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley and Sons Inc.
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7278564/ https://ncbi.nlm.nih.gov/pubmed/32406209 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15252/emmm.202012355 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|